Literature DB >> 11578848

Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B).

D I Zafeiriou1, P A Savvopoulou-Augoustidou, A Sewell, F Papadopoulou, M Badouraki, E Vargiami, N P Gombakis, G S Katzos.   

Abstract

Sanfillippo B syndrome (mucopolysaccharidosis (MPS) III, type B) is characterized by mild expression of the characteristic 'Hurler' phenotype and a severe central nervous system involvement. We report three patients with Sanfilippo B syndrome, referred to our clinic because of peculiar facies, delay in language development and behavioral problems, at the ages of 4, 3 and 5 years, respectively. At presentation they manifested clinical features of MPS, severe developmental retardation, radiological features of dysostosis mutiplex, as well as neurophysiological findings suggestive of carpal tunnel syndrome and sensorineural hearing impairment. Due to marked urinary excretion of heparan sulfate, as well as deficiency of alpha-N-acetylglucosaminidase in leukocytes, the diagnosis of Sanfilippo B syndrome was made. Serial brain magnetic resonance imaging (MRI) at different ages demonstrated white matter abnormalities, cortical atrophy and ventricular enlargement in all three patients, while other findings included thickening of the diploe in two patients and callosal atrophy, basal ganglia involvement, cerebellar changes and dilatation of venous sinuses in one patient. Although the combination of the above MRI findings is highly suggestive of a MPS, they carry a little predictive value in the different clinical stages of MPS IIIB.

Entities:  

Mesh:

Year:  2001        PMID: 11578848     DOI: 10.1016/s0387-7604(01)00242-x

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  18 in total

Review 1.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 2.  Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?

Authors:  Amauri Dalla Corte; Carolina F M de Souza; Maurício Anés; Roberto Giugliani
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

Review 3.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

Review 4.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

5.  Chronic subdural hematoma associated with mucopolysaccharidosis type III B (Sanfilippo's syndrome B).

Authors:  Toshinari Kawasaki; Masashi Kitagawa; Keita Suzuki; Takafumi Wataya
Journal:  Childs Nerv Syst       Date:  2016-03-07       Impact factor: 1.475

Review 6.  Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.

Authors:  E I Parker; M Xing; A Moreno-De-Luca; E Harmouche; M R Terk
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

7.  Mucopolysaccharidosis type IIIB (MPS IIIB) masquerading as a behavioural disorder.

Authors:  Jacqueline Brady; Aditi Trehan; Dennis Landis; Camilo Toro
Journal:  BMJ Case Rep       Date:  2013-05-08

8.  Blood-brain barrier impairment in an animal model of MPS III B.

Authors:  Svitlana Garbuzova-Davis; Michael K Louis; Edward M Haller; Hiranya M Derasari; Ashley E Rawls; Paul R Sanberg
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

Authors:  Coy D Heldermon; Anne K Hennig; Kevin K Ohlemiller; Judith M Ogilvie; Erik D Herzog; Annalisa Breidenbach; Carole Vogler; David F Wozniak; Mark S Sands
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

10.  Blood-brain barrier impairment in MPS III patients.

Authors:  Svitlana Garbuzova-Davis; Santhia Mirtyl; Sebastian A Sallot; Diana G Hernandez-Ontiveros; Edward Haller; Paul R Sanberg
Journal:  BMC Neurol       Date:  2013-11-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.